Positive news on cancer vaccine: On August 23, 2023, Moderna announced positive results from a clinical trial of its personalized cancer vaccine in combination with Merck's Keytruda. The trial showed that the combination therapy was effective in reducing the risk of relapse in patients with high-risk melanoma. This positive news is likely boosting investor...
